WEKO3
アイテム
Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Central Retinal Vein Occlusion
http://hdl.handle.net/10069/33894
http://hdl.handle.net/10069/338948987fbfc-86b5-416e-a311-a1b5d7ded707
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
AJO156_543.pdf (565.1 kB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2013-10-15 | |||||
| タイトル | ||||||
| タイトル | Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Central Retinal Vein Occlusion | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Subfoveal choroidal thickness | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Central retinal vein occlusion | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Enhanced depth imaging optical coherence tomography | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | intravitreal bevacizumab | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| 著者 |
Tsuiki, Eiko
× Tsuiki, Eiko× Suzuma, Kiyoshi× Ueki, Ryotaro× Maekawa, Yuki× Kitaoka, Takashi |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Purpose: To evaluate subfoveal choroidal thickness in patients with central retinal vein occlusion (CRVO) using enhanced depth imaging optical coherence tomography. Design: Retrospective observational study. Methods: We measured bilateral subfoveal choroidal thickness, averaged for 100 scans, in 36 patients (mean age, 66 ± 15 years; 26 women and 10 men) with unilateral CRVO by using the enhanced depth imaging methods of the Spectralis optical coherence tomography system. Twenty-two patients were treated with intravitreal bevacizumab (1.25 mg/0.05 mL), and subfoveal choroidal thickness was measured before and after treatment. Statistical analysis was performed to compare subfoveal choroidal thickness of CRVO and fellow eyes and to compare subfoveal choroidal thickness before and after intravitreal bevacizumab. Results: Mean subfoveal choroidal thickness measured in 36 eligible eyes of 36 patients was 257.1 ± 83.2 μm, which was significantly greater than that in fellow eyes (222.6 ± 67.8 μm; P <.01, paired t test). There was strong correlation between CRVO eyes and fellow eyes (r = 0.79, P <.01). Mean subfoveal choroidal thickness after intravitreal bevacizumab was 227.7 ± 65.1 μm, which was significantly thinner than that before intravitreal bevacizumab therapy (266.9 ± 79.0 μm; P <.01, paired t test). Conclusions: Subfoveal choroidal thickness of CRVO eyes was significantly greater than that of fellow eyes and decreased significantly after intravitreal bevacizumab treatment. Enhanced depth imaging optical coherence tomography can be used to evaluate choroidal involvement in CRVO and may assist noninvasive diagnosis and management of this disease. | |||||
| 書誌情報 |
American Journal of Ophthalmology 巻 156, 号 3, p. 543-547.e1, 発行日 2013-09 |
|||||
| 出版者 | ||||||
| 出版者 | Elsevier Inc. | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 00029394 | |||||
| DOI | ||||||
| 関連タイプ | isVersionOf | |||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.1016/j.ajo.2013.04.008 | |||||
| 権利 | ||||||
| 権利情報 | © 2013 by Elsevier Inc. All rights reserved. | |||||
| 権利 | ||||||
| 権利情報 | NOTICE: this is the author’s version of a work that was accepted for publication in American Journal of Ophthalmology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in American Journal of Ophthalmology, 156, 3(2013) | |||||
| 著者版フラグ | ||||||
| 出版タイプ | AM | |||||
| 出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||
| 引用 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | American Journal of Ophthalmology, 156(3), pp.543-547.e1; 2013 | |||||
